SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Romania
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Mediplus Exim

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Mediplus Exim SRL

Headquarters
Str. Ciobanului nr. 133; MOGOSOAIA; Ilfov
Status: Non-Listed
Legal Form: Limited Liability Company
Operational Status: Operational
CUI: 09311280
Incorporation Date: January 1, 2007
Total Employees: 900

Tel: 00 40-21-301.7474

Company Description

July 1994 - Plurifarm is established - import, distribution and promotion of OTC.
August 1996 - Farmactiv is established - import, distribution and promotion of OTC.
September 1997 - Mediplus is established - distribution of Rx pharmaceuticals.
August 1998 - Vivafarm is established - import, distribution and promotion of OTC.
September 1999 - Elantis is established - import, distribution and promotion of OTC.
September 1999 - All these companies are integrated under
More

Company Analysis

According to the Individual - Non-Audited financial statement for the Year of 2011, total net operating revenues increased with 15.88%, from RON 2,340,947,279 to RON 2,712,668,417 . Operating result increased from RON 48,889,265 to RON 58,990,156 which means 20.66% change. The results of the period increased 52.78% reaching RON 56,231,206 at the end of the period against RON 36,805,484 last year. Return on equity (Net income/Total equity) went from 13.64% to 25.87%, the Return On Asset (Net income / Total Asset) went from 1.72% to 2.18% and the Net Profit Margin (Net Income/Net Sales) went from 1.57% to 2.07% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 1087.19% compared to 690.96% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.10 to 1.05 when compared to the previous year.

Key Executives

Andreea Ionescu Marketing Manager
More

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Total Assets

2,580,261,661

2,341,703,674

Current Assets

X,XXX,XXX,XXX

X,XXX,XXX,XXX

Total Liabilities

X,XXX,XXX,XXX

X,XXX,XXX,XXX

Shareholders Equity

XXX,XXX,XXX

XXX,XXX,XXX

Current Liabilities

X,XXX,XXX,XXX

X,XXX,XXX,XXX

* All the accounts are in RON.
Income Statement

Total Operating Revenue

X,XXX,XXX,XXX

X,XXX,XXX,XXX

Operational Profit (Loss)

XX,XXX,XXX

XX,XXX,XXX

Net Profit (Loss)

XX,XXX,XXX

XX,XXX,XXX

* All the accounts are in RON.
Ratios
Profitability Ratios

Return on Assets (ROA)

X.XX%

X.XX%

Annualised Return on Assets (ROA)

X.XX%

X.XX%

Return on Equity (ROE)

XX.XX%

XX.XX%

Annualised Return on Equity (ROE)

XX.XX%

XX.XX%

Return on Sales (ROS)

X.XX%

X.XX%

Return on Capital

XX.XX%

X.XX%

Gross Profit Margin

X.XX%

X.XX%

Operating Profit Margin

X.XX%

X.XX%

Efficiency Ratios

Accounts Receivable Turnover

X.XXx

X.XXx

Inventory Turnover

X.XXx

X.XXx

Current asset turnover

X.XXx

X.XXx

Fixed-asset turnover

X.XXx

X.XXx

Asset Turnover

X.XXx

X.XXx

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

XX,XXX,XXX

XX,XXX,XXX

EBITDA

XX,XXX,XXX

XX,XXX,XXX

Bookvalue (BV)

XXX,XXX,XXX

XXX,XXX,XXX

Net Cash

-X,XXX,XXX,XXX

-X,XXX,XXX,XXX

Liquidity Ratios

Current Ratio

XXX.XX%

XXX.XX%

Quick ratio

XX.XX%

XX.XX%

Doom's day ratio

X.XX%

X.XX%

Leverage Ratios

Leverage ratio

X.XX%

XXX.XX%

Interest Coverage Ratio

XXX.XX%

XXX.XX%

Debt to equity

X.XX%

XXX.XX%

Debt to total assets

XX.XX%

XX.XX%

Long Term Debt to Capital

XX.XX%

XX.XX%